Company intelligence / Profile preview

BiOMOTUM

Portland, Oregon, United Statesbiomotum.com ↗

Ownership: Private
Development stage: Other

Overview

BiOMOTUM has developed the SPARK robotic exoskeleton system to deliver precise, quantifiable assistance and resistance during walking. Early pilot studies have shown promise in improving motor control in children with cerebral palsy. The device supports both clinical research and real-world rehabilitation settings but does not yet appear to be fully commercialized or approved as a medical device.

Therapeutic areas: Neurology
Modalities: DeviceRobotic exoskeletonNon-pharmacological therapy
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on BiOMOTUM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BiOMOTUM.

Explore the full profile